Skip to content
HowShorted

Keros Therapeutics, Inc. short interest in 2020

In 2020, Keros Therapeutics, Inc.'s disclosed short interest ran from 3.58% of shares outstanding on 15 Jul 2020 to 4.54% on 31 Dec 2020, a change of +0.96 percentage points. The year's high was 6.42% on 14 Aug 2020 and its low 2.30% on 15 Dec 2020, averaging 4.06% across 11 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.11 days on 15 Sep 2020. Full history: Keros Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Keros Therapeutics, Inc. in 2020

2020 in figures

Start of year
3.58% (15 Jul 2020)
End of year
4.54% (31 Dec 2020)
Change
+0.96 pp
High
6.42% (14 Aug 2020)
Low
2.30% (15 Dec 2020)
Average
4.06%
Highest days to cover
16.11 (15 Sep 2020)
SEC filings marked
6

Every report in 2020

Keros Therapeutics, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jul 20203.58%10.7110-Q filed, results (8-K)
31 Jul 20205.22%11.26
14 Aug 20206.42%14.8910-Q filed, results (8-K)
31 Aug 20205.38%11.00
15 Sep 20204.35%16.11
15 Oct 20203.21%3.48
30 Oct 20203.87%6.82
13 Nov 20203.12%6.8510-Q filed, results (8-K)
30 Nov 20202.64%2.43
15 Dec 20202.30%2.80
31 Dec 20204.54%3.69

See also: Keros Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.